Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Denmark

European Research Council grant · Running

OptiVision Clocking the conduction velocity of the visual pathway with optically pumped magnetometers

Coordinator
Aarhus Universitet, Denmark
Runs
1 January 2024 to 30 June 2026
Status
Running
EU funding
€150k
Total cost
—
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101138983

What the project is doing

In the project's own words, from its summary on CORDIS.

The human visual pathway carries high volumes of information from the retina to distant regions of visual cortex. The speed of this information transfer, retinocortical conduction time, has been proposed as a diagnostic measure of neurodegeneration. This conduction time has typically been estimated based on relatively slow evoked responses, although we now know that high-frequency activity in both the retina and visual cortex precede slower evoked responses by several tens of milliseconds.

In addition, the difference in timing between the onset of high-frequency activity in the retina and cortex is more in line with the expected conduction velocities of the heavily myelinated visual pathway. This project proposes to develop and validate a new sensor technology, optically pumped magnetometers (OPMs), to measure this high-frequency retinocortical conduction time, with a view towards establishing a diagnostic suitable for patients in the neurology and eye clinics to assess disease progression.

Impacts to myelination, circulation, and neural connectivity are all expected to reduce the conduction speed of the visual pathway, even before visual symptoms become apparent. The proposed high-frequency conduction time technique should provide a more accurate and sensitive measure to detect these impacts, with high potential for translation into a clinical diagnostic method. We will furthermore streamline the measurement procedure to increase the comfort, duration, and feasibility for potential patient groups.

Topics

Who is involved

OrganisationCityCountryRole
Aarhus UniversitetAarhus CDenmarkCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI